project id: TCGA-LUSC; case submitter id: TCGA-63-A5MH; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; age at index: 68; days to birth: -25159; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; age at diagnosis: 25159; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to last follow up: 2026.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: Yes; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.917808219178082; pack years smoked: 35.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-63-A5MH-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 14.0; percent tumor cells: 85.0; percent tumor nuclei: 90.0;